These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29845703)

  • 21. Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma.
    Birnie KA; Yip YY; Ng DC; Kirschner MB; Reid G; Prêle CM; Musk AW; Lee YC; Thompson PJ; Mutsaers SE; Badrian B
    Mol Cancer Res; 2015 Jul; 13(7):1106-18. PubMed ID: 25824152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.
    Kettunen E; Savukoski S; Salmenkivi K; Böhling T; Vanhala E; Kuosma E; Anttila S; Wolff H
    BMC Cancer; 2019 May; 19(1):507. PubMed ID: 31138176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma.
    Sudo H; Tsuji AB; Sugyo A; Abe M; Hino O; Saga T
    Int J Oncol; 2014 Feb; 44(2):530-8. PubMed ID: 24253341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.
    Meerang M; Bérard K; Felley-Bosco E; Lauk O; Vrugt B; Boss A; Kenkel D; Broggini-Tenzer A; Stahel RA; Arni S; Weder W; Opitz I
    Mol Cancer Ther; 2016 May; 15(5):1095-105. PubMed ID: 26839306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calpeptin Prevents Malignant Pleural Mesothelioma Cell Proliferation via the Angiopoietin1/Tie2 System.
    Tabata C; Tabata R; Nakano T
    Asian Pac J Cancer Prev; 2016; 17(7):3405-9. PubMed ID: 27509983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.
    Arzt L; Halbwedl I; Gogg-Kamerer M; Popper HH
    Pathol Oncol Res; 2017 Jul; 23(3):595-605. PubMed ID: 27987139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis.
    Plönes T; Fischer M; Höhne K; Sato H; Müller-Quernheim J; Zissel G
    Pathol Oncol Res; 2017 Oct; 23(4):723-730. PubMed ID: 28054314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mdm2 protein expression is strongly associated with survival in malignant pleural mesothelioma.
    Mairinger FD; Walter RF; Ting S; Vollbrecht C; Kollmeier J; Griff S; Hager T; Mairinger T; Christoph DC; Theegarten D; Schmid KW; Wohlschlaeger J
    Future Oncol; 2014 May; 10(6):995-1005. PubMed ID: 24941985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma.
    Digifico E; Erreni M; Mannarino L; Marchini S; Ummarino A; Anfray C; Bertola L; Recordati C; Pistillo D; Roncalli M; Bossi P; Zucali PA; D'Incalci M; Belgiovine C; Allavena P
    Front Immunol; 2023; 14():1116430. PubMed ID: 37398648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans.
    Yoda A; Oishi I; Minami Y
    J Recept Signal Transduct Res; 2003 Feb; 23(1):1-15. PubMed ID: 12680586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component.
    Matsumoto S; Nabeshima K; Hamasaki M; Shibuta T; Umemura T
    Med Oncol; 2014 Dec; 31(12):303. PubMed ID: 25358615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAR2 Regulates Malignant Behaviour of Mesothelioma Cells Independent of RNA-editing Activity.
    Sakata KI; Maeda K; Sakurai N; Liang S; Nakazawa S; Yanagihara K; Kubo T; Yoshiyama H; Kitagawa Y; Hamada JI; Iizasa H
    Anticancer Res; 2020 Mar; 40(3):1307-1314. PubMed ID: 32132027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
    Kanteti R; Riehm JJ; Dhanasingh I; Lennon FE; Mirzapoiazova T; Mambetsariev B; Kindler HL; Salgia R
    Sci Rep; 2016 Sep; 6():32992. PubMed ID: 27623107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma.
    Williams M; Kirschner MB; Cheng YY; Hanh J; Weiss J; Mugridge N; Wright CM; Linton A; Kao SC; Edelman JJ; Vallely MP; McCaughan BC; Cooper W; Klebe S; Lin RC; Brahmbhatt H; MacDiarmid J; van Zandwijk N; Reid G
    Oncotarget; 2015 Sep; 6(27):23480-95. PubMed ID: 26125439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAM10 mediates malignant pleural mesothelioma invasiveness.
    Sépult C; Bellefroid M; Rocks N; Donati K; Gérard C; Gilles C; Ludwig A; Duysinx B; Noël A; Cataldo D
    Oncogene; 2019 May; 38(18):3521-3534. PubMed ID: 30651596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, Laboratory, Histological, Radiological, and Metabolic Features and Prognosis of Malignant Pleural Mesothelioma.
    Zhang Y; Li R; Gu Y; LiZhu Y; Liu X; Zhang S
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557076
    [No Abstract]   [Full Text] [Related]  

  • 38. Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists.
    Urso L; Cavallari I; Silic-Benussi M; Biasini L; Zago G; Calabrese F; Conte PF; Ciminale V; Pasello G
    Oncotarget; 2017 Jul; 8(27):44232-44241. PubMed ID: 28562336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells.
    Bonelli MA; Digiacomo G; Fumarola C; Alfieri R; Quaini F; Falco A; Madeddu D; La Monica S; Cretella D; Ravelli A; Ulivi P; Tebaldi M; Calistri D; Delmonte A; Ampollini L; Carbognani P; Tiseo M; Cavazzoni A; Petronini PG
    Neoplasia; 2017 Aug; 19(8):637-648. PubMed ID: 28704762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell and extracellular matrix interaction models in benign mesothelial and malignant pleural mesothelioma cells in 2D and 3D in-vitro.
    Jagirdar RM; Papazoglou ED; Pitaraki E; Kouliou OA; Rouka E; Giannakou L; Giannopoulos S; Sinis SI; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):543-552. PubMed ID: 33336399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.